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Proteins constitute an important part of cell machinery that performs a plethora of functions. 
Here, we studied three different protein systems, the practical result of which is to indicate that 
proteins can be studied from different perspectives. We used multiple biophysical and 
biochemical approaches to probe protein-protein and protein-polymer interactions. Chapters 3 
and 4 focus on structural and thermodynamics aspects of protein-protein interactions, while 
chapter 5 has a more biochemical appeal in characterizing protein-polymer conjugates.  
Through NMR studies, we identified the binding interface of integrin β3 onto the Src SH3 
domain. We further tested the influence of tyrosine phosphorylation, a characteristic feature of 
activated β3 receptor. Additionally, we provide key insights into the role of phosphorylated β3 
and its interaction with Src kinase. Overall, the results from these studies contribute to our 
current understanding of Src mediated integrin signaling.  
Next, we performed a detailed study on calmodulin (CaM), which forms a globular compact 
structure upon binding with smooth muscle myosin light chain kinase (smMLCK). We 
modified CaM at its N- and C-termini and used the formation of disulfide bond to create an 
artificial circular protein. We studied the effect of this topological constraint on internal 
dynamics and molecular recognition. Using NMR relaxation techniques, we observed a slight 
reduction in the backbone mobility of the central loop and the C-lobe residues. ITC studies of 
Priya Katyal – University of Connecticut, 2016	
	
CaM with smMLCK revealed that in contrast to its linear counterpart, binding of cyclic CaM has 
a favorable change in entropy of binding (ΔS). Intriguingly, the overall Gibbs free energy of 
binding remained nearly constant between the two constructs.  
Lastly, we site-specifically linked enzymes to bi-functionalized polymeric scaffolds via 
bioorthogonal chemistry. We present a method to prepare functionally active Cel48F-cutinase 
engineered protein that can be site specifically linked with phosphonate-functionalized polymers. 
In addition, we also present the preliminary results of Cel48F-SNAP that can covalently bind to 
benzylguanine derivatives.  Our long-term goal is to prepare supramolecular protein-polymeric 
assembly that can mimic the natural cellulosome in catalyzing the conversion of cellulose to 
glucose, an important biochemical reaction in biofuel industry. 
Collectively, these studies used multifarious approaches to explore diverse protein-protein and 
protein-polymer interactions. 
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Chapter 1. Introduction 
The central dogma of molecular biology explains the flow of genetic information from DNA to 
RNA, which is further translated to make functional molecules, called proteins. Proteins 
constitute an important part of cell machinery that performs a magnificently diverse set of 
functions. They serve as structural components, are involved in cell signaling, catalyze reactions, 
acts as storage and transport molecules, and are therefore extensively studied. The interest in 
studying a specific protein arises from its participation in biologically relevant process. The 
biological properties a protein exhibits are conferred by its physical interaction with other 
molecules. These molecules, referred to as ligands can vary from being an ion, a small molecule 
or a macromolecule.  
In this thesis, each chapter details about a specific protein, the practical result of these diverse 
choices of proteins is to indicate that the proteins can be studied from one or more different 
perspectives.  
1.1 Synopsis 
 
The following subsections describe the broad focus of each chapter. 
1.1.1 Protein-protein interactions 
 
Proteins are inherently meant to work cohesively with other proteins or act in conjunction with 
other scaffolds to achieve their functionalities. A detailed understanding of protein-protein 
interactions is fundamental for a thorough evaluation of biological processes such as blood 
coagulation, inflammatory response, and also for certain diseased states like cancer. By 
		 2	
integrating structural characterization with emphasis on molecular details, we can precisely 
delineate the mechanisms and the forces governing protein-protein interactions. 
1.1.2 Effect of structural modifications on protein interactions 
 
Proteins are dynamic molecules, and because of observed flexibility they can adopt different 
conformations in apo and bound forms. The conformational change can influence the pathway in 
which the protein would be involved and can further regulate its function. Of the many methods, 
introduction of disulfide linkage has been proven successful to emulate the well-defined 
conformation of proteins or to lock them in their active conformations. Though considerable 
research has been done in studying disulfide engineered proteins, yet its important to characterize 
the modified protein and its impact on protein’s physical, chemical and biological properties.  
1.1.3 Engineered proteins and their interaction with polymers  
 
Subtle changes in proteins can result in customizable proteins with designed properties. New 
methodologies are being used to make analogues of naturally occurring proteins that show better 
stabilities, higher activities, and resistance to degradation with other desired properties. Given 
the importance of proteins in biotech industry and pharmaceutical applications, the redesigned 
proteins would likely be of great value with promising results. The field of chemical biology has 
recently been surged with designer catalytic machines, comprising of functionally active 
enzymes combined with synthetic polymeric scaffolds. The combination, typically called 
bioconjugates, has been increasingly used in biotechnology and biomedical research for 
widespread applications. 
Here, we first investigated the structural details of protein-protein interactions in signal 
transduction. Secondly, we attempted to understand how a small structural change in a protein’s 
conformation affects its dynamics and interaction. Lastly, we studied the interaction of 
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engineered proteins with synthetic polymers and compared the activity of the free protein with its 
polymeric conjugates.   
1.2 Aims of the thesis 
 
Following are the aims of the thesis: 
1. To study how tyrosine phosphorylation of β3 integrin modulates its binding with c-Src.   
2. To investigate binding and backbone dynamics of protein under topological constrain using 
calmodulin as a model system. 
3. To develop conjugates of Cel48F engineered protein with end-functionalized polymers. 
1.3 Overview of the thesis 
 
Following is an overview of the chapters in this thesis:  
Chapter 3 (section 3.5) of the thesis provides insights into the binding of integrin with Src SH3 
domain. We identified that the RGT motif of integrin sits between the RT and n-Src loop with 
tyrosine serving as a bridge. We also showed that the C-terminal residues of integrin adopt a 
polyproline type-II helix, which assists in binding of a non-PXXP motif to the Src SH3 domain. 
Additionally, we proposed a docking model of integrin binding to SH3 domain, and explained 
the importance of salt bridge formation of R760 of integrin CT with D117 of SH3.  
Chapter 3 (section 3.6) expands on the results presented in chapter 3 (section 3.5). Here, we 
identified and characterized the role of Src SH2 domain in binding to phosphorylated integrin. 
The interaction of integrin β3 with Src SH3 is abrogated upon phosphorylation of two tyrosines 
of β3CT, however recent studies have shown that phosphorylated integrin can remain bound to 
Src. We hypothesize that αIIbβ3, phosphorylated at its β3 tail, interacts with c-Src SH2 domain, a 
phosphotyrosine-recognizing domain. Our hypothesis is consistent with our preliminary NMR 
		 4	
titration data. We identified the key residues of integrin involved in mediating the interaction 
with Src SH2, that includes the phosphorylated tyrosine of β3 CT.  
In Chapter 4, we constrained the topology of calmodulin (CaM) and studied its effect on internal 
dynamics and molecular recognition by its binding partner, in particular smMLCK. For this 
study, we first synthesized the constrained version of CaM (referred as cyclized CaM) by 
introducing short cystine containing peptide sequences at its N- and C-termini. The formation of 
disulfide bond between the two cysteines (Cys) facilitates the cyclization of the protein. 
Intriguingly, we observed that the thermodynamic parameters of cyclized and linear (construct 
having no additional constrain) version contribute differently to free energy of binding, keeping 
ΔG constant. We also observed subtle differences in the order parameters of linear and cyclic 
CaM, indicating increased backbone rigidity in the loop regions of cyclized version.  
In Chapter 5, we reported development of polymer-protein conjugates of two fusion proteins 
with end-functionalized polymers.  We constructed two different fusion proteins comprising of 
cutinase tag and SNAP tag respectively, with our target protein, Cel48F (family 48), an 
important enzymatic member of Clostridium cellulolyticum cellulosome. We further compared 
the cellulase activity of these enzymes in free and conjugated states.  
Overall, these studies aimed to understand different protein-protein interactions and protein-
polymer interactions using diverse biophysical and biochemical techniques.   						
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Chapter 2. Characterization techniques 
Different biophysical and biochemical approaches were pursued to conduct the studies presented 
in this thesis. We primarily used Nuclear Magnetic Resonance (NMR) (except for chapter 4) for 
structural analysis. Other biophysical techniques, including circular dichroism (CD), isothermal 
titration calorimetry (ITC), differential scanning calorimetry (DSC), and mass spectroscopy 
(MS) were used to further characterize the different protein systems. A brief description of each 
technique is as follow: 
2.1 NMR spectroscopy of proteins 
 
NMR is a powerful tool to determine the structures and dynamics of the proteins in solution. 
There has been an increasing interest in studying protein-protein interactions under physiological 
conditions by using NMR spectroscopy. It is widely used to delineate the location of binding 
interface in protein-protein interactions, and is useful in providing site-specific information on 
backbone and side chain dynamics. Below are the brief discussions of the different NMR 
techniques used in the thesis.   
2.1.1 15N-HSQC (Heteronuclear Single Quantum Correlation) titration 	15N-HSQC based chemical shift mapping is uniquely suited to identify protein-ligand binding 
interfaces. Owing to its high sensitivity, it is widely used in NMR. Titrating the unlabeled 
compound into a solution of the labeled protein identifies the binding surface on 15N-labeled 
target. The associated spectral changes in the 1H-15N HSQC spectra are monitored and mapped 
onto the surface of protein (with known domain fold) to identify the binding site. The chemical 
shifts are measured at each titration point. The chemical shift changes are converted to chemical 
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shifts perturbations, which are further plotted with respect to residue numbers [1]. Delta (ppm) 
refers to the combined HN and N chemical shift changes according to the equation:  
Eq. 1.                      Δδ(HN,N) = ((ΔδHN)2 + 0.2(ΔδN)2)1/2, 
                            where Δδ = δbound – δfree 
During titration, apart from chemical shifts perturbations, its common to observe signal 
broadening or complete disappearance of the peak. Such results point towards the complex 
exchange regime of the proteins involved. The simple case of observing smooth chemical shift 
perturbations in NMR spectra, suggest the system is under fast exchange (having a faster Koff 
rate) and thus, we observe a weighted average of free and bound states. Other exchange 
processes affect NMR, including slow and intermediate exchange and its possible to observe 
different exchange regimes within the same biomolecule. If the Koff rate is slower than the 
chemical shift difference between the free and bound states, then two different resonances are 
observed, one from free and the other representing bound signal in the spectra. As the ligand is 
titrated in, the free peak disappears with an increase in intensity of bound peak.  The intermediate 
exchange is defined when the exchange rate is similar to the shift difference, and the resultant 
free and bound signals coalesce into one broad peak. Broadened peak, however, doesn’t always 
indicate slow/intermediate exchange, and it is worthwhile to use other characterization 
techniques to get more information[2].  
2.1.2 Transferred NOESY 
 
TrNOESY experiments are suitable for weakly associating systems, where the molecular weight 
of the macromolecule is large compared to the ligand. It helps in identifying the bound 
conformation of ligand, which are under fast exchange. Since the off rate is fast, the rate of NOE 
build-up differs between the free and bound states. When the ligand is bound, it tends to tumble 
		 7	
with the macromolecule, thus having a faster rate of NOE formation. This phenomenon is 
observed by the presence of additional peaks in the NOESY spectra, when ligand is used in 
excess concentration.  
2.1.3 Paramagnetic Relaxation Enhancement (PRE) experiments 
 
PRE experiments provide unique long-range distance (10-25 Å) information that can 
complement NOEs, which are limited to distances of up to 5 Å. A paramagnetic label is 
covalently attached to one of the binding partner to produce distance-dependent line broadening 
in the NMR spectra. PRE profile (ratio of NMR signal intensities in the paramagnetic and 
diamagnetic state) of tagged mutants is determined, and the line broadening of the residues are 
used to map the orientation of the bound peptide. The line broadening is a result of increased R2 
relaxation rates, described by Solomon-Bloembergen equation.  
Eq. 2. 
  
Where r is the distance between the electron and nuclear spins, τc is correlation time for this 
electron-nuclear interaction, ωh is the Larmor frequency of this nuclear spin (proton) and K is a 
constant. 
2.1.4 Triple resonance Experiments 
 
An important step in assigning the HSQC spectra is to perform the backbone/sequential 
assignments using multidimensional NMR experiments. These set of experiments involve 
transfer of magnetization between 1H, 15N and 13C atoms. The standard suite for backbone 
assignment contains of experiments HNCA, HN(CO)CA, HNCACB, HN(CO)CACB, HNCO 
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and HN(CA)CO. We can detect Cα, Cβ and CO groups of the given residue (i) and also for (i-1) 
in certain spectra. The correlation and the information given by each spectra are as listed (the 
signals from the nuclei in parentheses are not detected):   
 
S.No. Experiment Information about i and i-1 
residues 
1. HNCA Cαi Cαi-1   
2. HN(CO)CA Cαi-1    
3. HNCACB Cαi Cαi-1 Cβi Cβi-1 
4. HN(CO)CACB Cαi-1 Cβi-1   
5. HN(CA)CO COi COi-1   
6. HNCO COi-1    
 
Table 2.1. Standard suite for backbone assignments. The above experiments are performed in 
pairs to assign the Cα, Cβ and CO groups of the i and i-1 residues. 
 
Experiments 1&2, 3&4, 5&6 are compared in pairs to give information about the residue (i) and 
the preceding residue (i-1). For example, HNCA spectrum gives information about residue (i) 
and (i-1). The (i-1) residue is sequence confirmed by comparing the chemical shifts of the peaks 
in HNCA and HN(CO)CA spectra. 
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Figure 2.1 Triple resonance experiments for backbone assignments. The arrows indicate transfer 
of magnetization between the atoms involved. The figure was modified from [3].  
 
2.1.5 NMR Relaxation experiments  
 
Relaxation can be defined as the return of magnetization to its equilibrium state. Predominantly, 
we observe T1 and T2 relaxation:  
•  T1 relaxation (also known as longitudinal or spin-lattice relaxation time) is the rate at 
which z component of magnetization returns to equilibrium after perturbation.  
•  T2 relaxation (also known as transverse or spin-spin relaxation time) is the rate at which 
xy component of magnetization returns to equilibrium after perturbation.  
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Figure 2.2 The net nuclear magnetization M0 is aligned along the z axis. When irradiation 
begins, all of the individual nuclear magnetic moments become phase coherent, and this phase 
coherence forces the net magnetization vector M to process around the z axis. (a) Longitudinal 
relaxation causes recovery of the longitudinal (z) component of magnetization (from black to 
grey) toward M0, at an exponential rate with time-constant T1. (b) Transverse relaxation causes 
shortening of the transverse component of magnetization (from blue to red), at an exponential 
rate with time-constant T2. The figure was taken from [4]. 
  
Another relaxation parameter commonly studied is the heteronuclear nuclear Overhauser effect 
(NOE) where we saturate the 1H signals and observe the associated changes in 15N signal. These 
three relaxation parameters serve to determine the dynamics of the proteins in solution.  
In order to relate T1, T2 and NOE with dynamics, its worth to mention the spectral density 
function (J(ω)). J(ω) describes the effect of motion on relaxation rate and is further related to S2, 
the order parameter. S2 is the generalized order parameter, which describes the amplitude of fast 
motions experienced by the individual NH bond vectors. High S2 values, approaching 1, indicate 
limited motions and greater rigidity, whereas lower values indicate increasingly larger amplitude 
motions and greater flexibility. 
2.2 Circular Dichroism (CD) 
 
Circular dichroism is an excellent tool to determine the secondary structure of proteins. It 
estimates the likelihood of a protein being in a helix, beta sheet or in random coil. Each 
		11	
secondary element gives a characteristic CD spectrum in the far UV spectral region (190-
240nm). α-helical proteins have negative bands at 222 nm and 208 nm and a positive band at 193 
nm. Proteins with β-pleated sheets have negative bands at 218 nm and positive bands at 195 nm, 
while disordered proteins have a negative band near 195 nm. Additionally, extended 310 helix or 
poly-proline type II helix gives a negative band around 200nm and weaker positive band near 
217nm [5].  
      
Figure 2.3 Representative CD spectra of different secondary structures. Solid line, α-helix; long 
dashed line, anti-parallel β-sheet; cross dashed line, extended 310-helix or poly (Pro) II helix; 
short dashed line, irregular structure. The figure was taken Kelly S.M. et al., Biochimica et 
Biophysica Acta - Proteins and Proteomics, 2005 [5].  
 
2.3 Calorimetric techniques 
 
2.3.1 Isothermal Titration Calorimetry (ITC) 	
 ITC is a quantitative technique that can determine the complete thermodynamic profile (n, K, 
ΔH and ΔS) of the interaction in a single experiment. It measures the heat change on formation 
of a complex, when a ligand (L) is injected into the macromolecule (M) [6]. The heat released or 
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absorbed upon each injection of a ligand is measured with respect to the reference cell containing 
only the buffer. The raw data includes the plot of heat change required to maintain isothermal 
conditions between the sample and the reference cell. The individual peaks are further integrated 
and plotted with respect to total ligand-protein ratio to give the sigmoidal binding curve. The 
binding enthalpy (ΔH) is calculated by measuring the total heat change, while the slope of the 
curve gives the association constant (Ka) [7]. These parameters are further used to calculate 
Gibbs free energy (ΔG) and entropy of binding (ΔS) using the following equation:  
Eq. 3. 
 
 
2.3.2 Differential scanning calorimetry (DSC) 
 
DSC is a thermal technique, used to characterize the stability of the proteins. It measures the heat 
change required to denature the protein and is useful in calculating the Tm, the thermal transition 
midpoint of proteins. The Tm is the temperature at which the proteins have equal concentrations 
of native and unfolded conformations  (at equilibrium). The reference and the sample cells are 
maintained at the same temperature as they are heated. The difference in the amount of heat 
required to maintain the temperature of sample cell equivalent to that of reference cell is plotted 
with respect to temperature. 
2.4 Mass spectrometry  	
Mass spectrometry (MS) involves separation of molecules according to mass/size ratio. While 
intact protein MS is routinely used to verify the identity of proteins, the approach of MS/MS 
(alongwith with the use of trypsin digestion) allows identification of protein sequences and 
localization of sites of modifications. 
ΔG         = - RT lnKa 
 
ΔG
binding 
= ΔH
binding
-   TΔS
binding
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Chapter 3. Integrins and its interaction with c-Src kinase 
3.1 Integrins 
 
3.1.1 Architecture of integrins 
 
Integrins are a family of αβ heterodimeric receptors that act as cell adhesion molecules 
connecting the extracellular matrix (ECM) to the actin cytoskeleton[1]. Each integrin subunit, α 
and β, contains a large extracellular domain, a transmembrane (TM) domain, and a short 
cytoplasmic tail. The extracellular head of integrins is composed of several domains- the α 
subunit is composed of a propeller, a thigh, and two calf domains while the β subunit consists of 
a PSI domain, a hybrid domain (with an inserted I/A domain), four I-EGF domains, and a tail 
domain[2]. On the contrary, the cytoplasmic tails of α and β subunits are small (Figure 3.1), 
which are connected to the extracellular head via single spanning trans-membrane helix[3].  
 
Figure 3.1 Architecture of integrin αIIbβ3 and schematic representation of integrin activation. In 
inactive state, the α and β subunits are in close association with headpiece in a bent 
conformation. Subsequent to integrin activation, the two subunits are separated and the 
headpiece straightens up, resulting in an extended integrin conformation. The α subunit is shown 
in green and the β subunit in violet. The figure was modified from Moser, M. et al., Science, 
2009 [4]. 
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3.1.2 Integrin signaling 	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Bidirectional Integrin signaling. The right panel shows the inside-out signaling while 
the left panel represents the steps involved in mediating outside-in signaling. The figure was 
taken from Shattil, S.J. et al., Nat Rev Mol Cell Biol, 2010 [5].  
  
 
Integrins have unique characteristic of signaling bidirectionally, termed as inside-out and 
outside-in signaling (Figure 3.2). Of the 24 different integrin receptors, assembled form 18 α and 
8 β subunits, αIIbβ3, an archetypical representative of the class, regulates platelet aggregation and 
serves as a molecular scaffold interacting with various extracellular and intracellular binding 
partners [1]. Unstimulated platelets express αIIbβ3 in a conformation inaccessible to ligands, 
preventing platelet-platelet interaction [3, 6]. In inactive state, the α and β subunits are in close 
association with the headpiece in a bent conformation. Inside-out signaling, initiated by 
separation of heterodimeric cytoplasmic tails cause an overall conformational change that 
propagates across the membrane to the extra-cellular domain of the receptor [3]. The 
extracellular domain of αIIbβ3 binds to its ligands with a high affinity and couples the platelets 
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together to form an aggregate [3, 6]. An increase in ligand binding induces a cascade of signaling 
events into the cell, collectively referred to as outside-in signaling[1]. The integrin β3 
cytoplasmic tail (CT) is involved in propagation of outside-in signaling by binding to protein 
tyrosine kinases (PTKs) and other signaling proteins [1, 7, 8].  
3.1.3 Role of β3 Cytoplasmic tail in signaling  			
		
Figure 3.3 Binding of different adaptor proteins along the sequence of β3 cytoplasmic tail. The 
lines indicate the motifs involved in binding to β3 tail. Tyrosine-bearing motifs are colored in 
blue. The figure was modified from Legate, K.R. et al., J Cell Sci, 2009 [9]. 	
 
β3 cytoplasmic tail is devoid of any catalytic activity but is composed of 47 residues comprising 
of various motifs to which many of the proteins and kinases have been shown to bind (Figure 
3.3)[9]. The different motifs include the membrane proximal HDRK motif, known to bind 
skelemin, FAK and paxillin [10, 11]; the adaptor binding tyrosine-bearing motifs, namely, 
NPXY and NXXY. Upon integrin activation, these tyrosines get phosphorylated and act as a hub 
for proteins containing PTB domains, like Shc, DokI, and many others [12, 13]. More recently, 
the C-terminal RGT motif has been shown to bind Src kinase. This interaction between integrin 
and Src kinase is identified to have important role in outside-in signaling and has been a subject 
of intensive research [7, 14, 15].   
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3.2 Src kinase  
 
3.2.1 Structural organization of Src 	
		
Figure 3.4 Structural representation of full length Src (PDB: 2SRC)[16]. The different domains 
are color coded as pink: SH3 domain, cyan: SH2 domain, blue: catalytic domain, green: pY527 
bearing C-terminal tail.  
 
 
c-Src belongs to the family of Src family protein tyrosine kinases (SFKs), other members include 
Fyn, Yes, Blk, Fgr, Hck, Lck, Lyn, and Yrk. c–Src, Fyn and Yes are ubiquitously expressed 
while other members are expressed in specific tissues. All the members are structurally similar 
and consist of SH3, SH2 and kinase domain [17].  
The c-Src kinase is a multi-domain protein tethered to the plasma membrane by a N-terminal 
myristoylation sequence [16]. It consists of a (i) unique domain (ii) SH3 domain, (iii) SH2 
scaffold domain, and (iv) catalytic kinase domain, followed by a tyrosine (Y527) containing C-
terminal regulatory sequence. The intramolecular interactions between the domains including (i) 
the interaction between the SH3 domain and the linker connecting the SH2 and kinase domains, 
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and (ii) the binding of SH2 domain to the phosphorylated Y527 at the C-terminal tail of the kinase 
domain, maintain Src in a resting state with a closed conformation [18]. v-Src, the first oncogene 
isolated from Rous Sarcoma Virus, was found to lack the C-terminal region that contains Tyr527, 
making it continually active [19].  
Typically, Src is maintained in an inactive state, but gets activated transiently during cellular 
events such as mitosis, or upon adhesion of platelets to fibrinogen [20].Abnormal activation of 
Src, either by mutation (as in v-src) or loss of regulatory control, can lead to drastic results with 
repercussions in several cancers, including colon and breast cancer [21].  
3.2.2 Regulation of Src 	
 
 
Figure 3.5 Model of c-Src activation by β3. The figure was taken from Huveneers S., et al., 
Scientific World Journal, 2010 [21].  
 
The tyrosine phosphorylation status of Src regulates its activity, the key residues being Y416 and 
Y527. Phosphorylation of Y416 activates the kinase whereas when Y527 is phosphorylated, it serves 
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as a negative regulator of Src activity. Csk, a C-terminal Src kinase associates with Y527 of c-Src; 
the phosphorylated Y527 further interacts with SH2 domain of Src, suppressing Src activity [16, 
22]. On the contrary, PTP-1B, a phosphatase dephosphorylates Y527, relieving this inhibitory 
interaction [8, 18]. Various factors, including association of Src with its binding partners, trigger 
trans-autophosphorylation of Y416 (present within the activation loop of Src), resulting in an 
increased catalytic activity of Src kinase (Figure 3.5). 
3.3 Role of integrins in Src activation 
 
Several studies have shed light on the importance of interaction of integrins with Src. The 
interaction has been implicated in platelet adhesion, cytoskeletal reorganization and bone 
remodeling. Integrins (upon its interaction with the extracellular matrix) cluster and congregate 
several signaling and adaptor proteins [1, 23]. These sites of integrin clusters are involved in 
formation of focal adhesions that regulate diverse arrays of cellular functions such as cell 
motility, migration, differentiation and proliferation [1]. One of the initial events that occur upon 
integrin activation is the increase in catalytic activity of SFKs [24]. Src kinase plays an important 
role in mediating integrin dependent adhesion signaling by phosphorylating other downstream 
kinases and adaptor proteins. De Virgilio (2004) showed the close proximity of αIIbβ3 and Src in 
living cells, using Bioluminescence resonance energy transfer (BRET) and bimolecular 
fluorescence complementation (BiFC) [25]. Biochemical studies have emphasized that integrin 
not only acts as a substrate for Src kinase [26] but is also believed to bind Src SH3 domain 
through its terminal residues, in particular the RGT motif. However, until the beginning of the 
current studies, it wasn’t clear as where the RGT motif binds the SH3 domain. The present study 
was carried out to address this issue. A better understanding is warranted, as myriad of details 
remains elusive about the integrin mediated Src activation. 
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3.4 Clinical significance 
 
Extensive studies of both, integrin and Src kinase, have established a critical role of this 
interaction in thrombosis and hemostasis as well as in regulation of platelet adhesion [27]. 
Current pharmacological approaches to prevent platelet-dependent thrombotic complications of 
cardiovascular disorders include αIIbβ3 antagonism with inhibitors of ligand binding at the 
extracellular matrix [28]. A novel antithrombotic approach targeting of αIIbβ3 signaling at the 
level of β3 extreme C-terminus using β3-derived membrane permeable myristoylated peptides has 
been proven successful [29]. However, there is still an unmet need for more effective and safe 
antiplatelet drugs for chronic indications. Our studies reveal not only the structural details of new 
therapeutic targets for the treatment of thrombosis and neoplastic diseases, but also provide new 
insights into understanding the molecular details of the fundamental process of platelet adhesion 
and c-Src activation.  
Outline 
In this project, we focused our efforts in studying the association of β3 cytoplasmic tail with c-
Src. Section 3.5 provides insights into the binding of integrin with Src SH3 domain. We 
identified that the RGT motif of integrin sits between the RT and n-Src loop with tyrosine 
serving as a bridge. We also showed that the C-terminal residues of integrin adopt a polyproline 
type-II helix, which assists in binding of a non-PXXP motif to the Src SH3 domain. 
Additionally, we proposed a docking model of integrin binding to SH3 domain, and explained 
the importance of salt bridge formation of R760 of integrin CT with D117 of SH3.  
Section 3.6 expands on the results presented in section 3.5. Here, we identified and characterized 
the role of Src SH2 domain in binding to phosphorylated integrin. The interaction of integrin β3 
with Src SH3 is abrogated upon phosphorylation of two tyrosines of β3CT, however recent 
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studies have shown that phosphorylated integrin can remain bound to Src. We hypothesize that 
αIIbβ3, phosphorylated at its β3 tail, interacts with c-Src SH2 domain, a phosphotyrosine-
recognizing domain. Our hypothesis is consistent with our preliminary NMR titration data. We 
identified the key residues of integrin involved in mediating the interaction with Src SH2, and 
identified the integrin-binding interface on Src SH2. Further experiments are necessary to fully 
characterize the interaction, and to expound its functional relevance in integrin-Src signaling 
pathway. 
3.5 Structural insights into the recognition of β3 integrin cytoplasmic tail by 
the SH3 domain of Src kinase 
 
3.5.1 Overview 
 
Shattil and co-workers [7, 8] have shown that outside-in signaling in platelets is mediated by a 
direct interaction of carboxyl terminus β3 integrin with SH3 domain of Src kinase. Src SH3 
domain, has been extensively studied and structurally characterized in both free and ligand 
bound states (PDB: 1RLQ, 1QWF, 1NLP). It consists of two antiparallel β sheets positioned at 
right angles to one another. The β strands are linked via RT loop, n-Src loop, distal loop, and a 
short 310-helix [30, 31]. In general, SH3 domains are known to favor peptides bearing a PxxP 
motif [32]. The PxxP motif adopts a polyproline type II (PPII) helix and binds between the RT 
loop and n-Src loop. The selectivity of these peptides is further enhanced by basic residues, 
arginines or lysines, which flank the core motif. In addition, other mechanisms may contribute 
towards the specificity of this interaction with the SH3 domain [33]. Although two classes of 
peptides, class I—(R/K)xxPxxP and class II—PxxPx(R/K), [32-34] are considered as canonical 
SH3 binding targets, accumulating evidence suggests that SH3 can also recognize non-PxxP 
motifs [32, 35, 36]. The exact molecular details of such recognition still remain unclear. 
		22	
However, some non-PxxP peptides have been shown to occupy the same interface as PxxP 
motifs [37]. 
In this project, we present the NMR data and a docked model of SH3 with cytoplasmic integrin 
β3. We also show that the C-terminal RGT motif of β3 adopts a partial PPII type helix facilitating 
its interaction with the RT and n-Src loops of SH3 in an orientation opposite to that obtained 
from X-ray studies [14].	 Finally, NMR titration studies demonstrate no interaction with the 
phosphorylated β3, supporting the idea of a constitutive interaction between non-
stimulated/resting (non-phosphorylated) β3 integrin and the SH3 domain of Src kinase. 
3.5.2 Materials and methods  	
Peptides 
 
β3 heptapeptide (NITYRGT762), mono (ATSTFTNITpYRGT762), and bi-phosphorylated 
(RAKWDTANNPLpYKEATSTFTNITpYRGT762) C-termini of β3 (MP-Cβ3 and BP-β3 
respectively) were synthesized chemically (Genemed Synthesis; NEO-peptides). 
Expression and purification 
 
Cloning, expression, and purification of cytosolic β3 was done as described elsewhere [3]. The 
human Src SH3 (residue 80–144) in pGEX-4T1 vector was expressed in BL21(DE3) after 
induction with 1mM IPTG. To produce 15N-isotopically labeled Src SH3, cells were grown in 
M9 minimal media containing 15NH4Cl. GST-tagged SH3 was purified in PBS buffer (140mM 
NaCl, 27mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4, pH 7.2) using Pierce Glutathione Agarose 
resin (Thermo Scientific). SH3 was eluted by either cleavage with thrombin or by using 10mM 
glutathione in PBS buffer. The eluate was further purified through HiLoad 16/60 Superdex 75 
column (GE Healthcare) equilibrated with PBS buffer.  
NMR spectroscopy  
		23	
All experiments were performed at 25°C using 0.1mM protein samples (unless otherwise 
mentioned), on 600 MHz magnet (Agilent) equipped with inverse-triple resonance cold probe.  
15N-HSQC titration 
Concentrated stock solutions of β3 peptides were prepared in the same buffer as Src and added to 
the 15N-labeled SH3 domain at different peptide to protein molar ratios. Each data point was also 
reverse titrated beginning from the saturated conditions for the peptides. Experiments were 
performed at pH 5.8. The SH3 spectra at different pH were collected as a negative control. All 
the spectra were collected with 2048 complex data points in t2 and 128 increments in t1 
dimensions and zero filled to 2048 x 1024 data points. The spectra were processed with 
NMRPipe and analyzed by CCPN software suite [38].	 Chemical shift assignments for SH3 
domain were obtained from BMRB database entry 3433 [31]. The shifts were adjusted to match 
our experimental conditions.  
Transferred NOE 
β3 heptapeptide was mixed with GST-fused SH3 at pH 6.5. Different peptide to SH3 ratios were 
investigated to find the optimal one for NOE transfer in two-dimensional proton NOESY 
experiments with the mixing time of 400 ms. A negative control with just the GST tag was 
performed under the same conditions at an optimized heptapeptide to GST ratio of 200 to 1. 
Partial 1H resonance assignments for the heptapeptide were obtained by collecting TOCSY 
(mixing time of 70 ms) and NOESY (mixing time of 400 ms) spectra. 
Paramagnetic Relaxation Enhancement (PRE) experiment 
 
In order to introduce a spin label, β3 mutant was constructed with an additional cysteine residue 
after the terminal YRGT sequence using QuikChange site-directed mutagenesis kit (Agilent). 
Prior to the reaction, the mutant was reduced by 1mM TCEP, which was subsequently removed 
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by washing on a PD-10 column (GE Healthcare). The reduced β3 mutant was allowed to react 
overnight with either an excess of cysteine specific spin label, 3-maleimido-PROXYL, hereafter 
referred to as mProxyl (Sigma-Aldrich), or 1-oxyl-2,2,5,5-tetramethylpyrroline-3-methyl) 
methanethiosulfonate, hereafter referred to as MTSL (Alexis Biochemicals). The reactions were 
performed at room temperature at a pH of 7.0. The unreacted spin label was separated from the 
tagged mutant by reverse phase HPLC on PROTO C4 column (The Nest Group). Attachment of 
the tag was confirmed through mass spectrometry. 15N -HSQC spectrum of SH3 in the presence 
of tagged β3 mutant (as well as a control with untagged mutant) was collected under the same 
conditions as used for wild type β3 titrations. 
Circular dichroism 
 
CD experiments were done on PiStar 180 Spectrometer (Applied Photophysics, UK). The sample 
was prepared by dissolving β3 heptapeptide in 20 mM phosphate buffer at pH 6.5. Spectrum was 
collected in the far UV range at 25°C with a step resolution of 0.5 nm, bandwidth of 3.0 nm and 
data averaging of 30 s/point. 
Electrostatic potentials mapping 
 
The potential files used for mapping were prepared from the respective PDB files by Adaptive 
Poisson–Boltzmann Solver (APBS) [39],	a program that maps the electrostatic potential energy 
based on Poisson–Boltzmann equation. The resultant (.pqr and.in) files from pdb2pqr webserver 
served as input for APBS calculations. APBS webserver as well as Chimera’s APBS built-in tool 
were used to prepare the electrostatic potential maps, which further rendered the electrostatic 
surface using Chimera’s Electrostatic Surface Coloring tool. Alternatively the surface potential 
was also directly mapped using Coulombic surface mapping. 
3.5.3 Results 
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Previous studies have identified the C-terminal RGT762 motif of β3 integrin [7, 27] as the binding 
site for Src kinase through its SH3 domain. Hence we decided to map the binding site of this 
interaction onto the surface of SH3 using solution NMR. First, the full length unlabeled 
β3 cytoplasmic tail (hereafter referred to as β3CT) was titrated against 15N  -labeled SH3. The 15N  
-HSQC spectra of SH3, shown in Figure 3.6, clearly indicate significant chemical shift 
differences when compared to the spectrum from free protein (shown in black). This titration 
was performed at an SH3 to β3 molar ratios of 1:1, 1:3, and 1:5 while maintaining a constant pH 
throughout the experiment. The observed chemical shift differences, shown in Figure 3.7 (a), 
were concentration dependent, reproducible, and specific to the interaction. Additionally, control 
experiments with the SH3 domain at different pH showed no similar effect, validating the 
perturbations being a consequence of binding. Amino acids affected the most, belong to the RT 
loop (residues R95 to L100) and the n-Src loop (E115 to W118), with Y131 perturbed in isolation. The 
RT loop amide peaks (R95, T96) were broadened upon titration, a manifestation of conformational 
exchange [4] (Fig. 3.7(c) and also shown in Fig. 3.8); while the peak intensities corresponding to 
the residues from the n-Src loop remained unaffected, suggesting a single conformation within 
this loop. Next, we tested β3 heptapeptide, composed of the last seven β3 residues containing the 
RGT motif. Chemical shift perturbation pattern obtained with β3 heptapeptide (Fig. 3.7 (b)) 
closely resembled the one obtained with the full-length β3CT. The insets in Figure 3.7 represent 
the mapping of the chemical shifts onto the surface of SH3 domain (PDB: 1SRL) in the presence 
of full-length β3CT (Fig. 3.7 (a)) and β3 heptapeptide Fig. 3.7(b). The similar binding interfaces 
between the two confirms that the C-terminal motif of β3 is sufficient to define its binding to Src 
SH3 domain. 
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Figure 3.6 The superimposition of 15N  -HSQC spectra of Src SH3 (shown in black) in the 
presence of varying molar excess of β3CT as shown in blue (1:1), green (1:3) and red (1:5). Also 
shown to the right are several individual residues displaying significant shifts. 
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Figure 3.7 (a) Chemical shift differences in SH3 HSQC spectra upon β3CT binding at different 
molar ratios. Bars are colored according to the different ratios as presented in Figure 3.6; Delta 
(ppm) refers to the combined HN and N chemical shift changes according to the equation: 
Δδ(HN,N) = ((ΔδHN2 + 0.2(ΔδN)2)1/2, where Δδ = δbound − δfree; The inset shows the chemical shift 
differences (obtained from 1:5 ratio) mapped onto the surface of SH3 domain (PDB: 1SRL), 
where the darker color represents the residues maximally affected. (b) Chemical shift differences 
obtained from the 15N   HSQC spectrum of SH3 upon binding to β3 heptapeptide also at 1:5 ratio, 
further mapped onto the surface of SH3 domain (inset). (c) Paramagnetic relaxation 
enhancement data of the backbone amide groups of SH3 in the presence of PRE tagged β3CT 
(green) in comparison to the untagged β3CT (orange). The asterisk mark represents proline 
residues. 
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Figure 3.8 Superimposition of the 15N  -HSQC spectra of SH3 in the presence of wild type β3CT 
(orange) and mutant with paramagnetic tag attached to its C-terminus end (green). The inset 
shows surface representation of the docked SH3 model with the heptapeptide (orange) and 
heptapeptide with PRE tag (green, attached tag is shown in yellow). 
 
We further used the chemical shifts mapping approach to test the influence of tyrosine 
phosphorylation, a characteristic feature of activated β3 receptor, [40], on its binding to Src 
kinase. These titrations were performed against 15N-labeled SH3 with mono-(pY747) or bi-
(pY747&pY759)-phosphorylated β3-derived peptides (MPCβ3 and BPβ3 respectively, refer to the 
Material and Methods section). Since no chemical shift differences were found in either case, 
even at a high molar ratio of 1 to 5 (Fig. 3.9), we concluded that tyrosine phosphorylation 
prevents SH3 from binding to β3. This finding is consistent with the previously suggested 
mechanism of constitutive interaction of Src with unactivated/resting, non-phosphorylated 
integrin β3 [7]. 
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Figure 3.9 Superimposition of the 15N  -HSQC spectra of SH3 obtained alone (green) and in the 
presence of peptides: C-terminus monophosphorylated β3 (MPCβ3) (blue), and biphosphorylated 
β3 (BPβ3) (red). 
 
We additionally carried out Paramagnetic Relaxation Enhancement (PRE) experiments to 
ascertain the orientation of bound integrin. A paramagnetic spin label was attached to the 
β3 mutant containing a cysteine residue added to its C-terminal end (Figure 3.10). The nitroxide 
radical from the spin label attenuates peak intensities of nearby residues allowing direct mapping 
of its location onto the binding surface. Since the label is attached next to the RGT motif, 
		30	
maximum attenuation is expected for SH3 residues adjacent to the ones involved in binding of 
this motif. To test whether the addition of a paramagnetic tag affected the interaction, we 
compared the spectra of SH3 in the presence of wild type β3CT and its tagged mutant (Fig. 3.8). 
Since no significant differences were observed we proceeded with the PRE analysis to study this 
interaction.15N -HSQC spectra were collected at an SH3 to β3 mutant ratios of 1:2 and 1:4. Peak 
intensities for SH3 in complex with the tagged β3 mutant were normalized to the intensities of 
SH3 in complex with the untagged mutant. Maximum attenuation was observed for the residue 
N135 (with its side chain signals broadened beyond detection; Fig. 3.8) and a moderate decrease 
for Y136 suggesting their close proximity to the tag. A moderate decrease in the intensities of the 
n-Src loop also confirmed its positioning near-to the β3 RGT motif, while the RT loop was less 
affected, showing similar intensities to the bound untagged β3 (Fig. 3.7 (c), shown in orange). 
Attaching the tag to a cysteine residue present at the end of the C-terminus makes it quite 
flexible, hence preventing the quantitative analysis of the PRE data for structure calculations. 
However, having the N135 residue from the SH3 domain in close proximity to the nitric oxide 
from the tag, allowed us to reliably predict the orientation of the RGT motif within the SH3 
binding interface. 
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Figure 3.10 (a) Chemical structure of PRE tags:	  3-maleimido proxyl and MTSL. (b) MS 
spectrum of m-proxyl tagged β3 		
To further define the molecular details of the complex, in particular, the conformation of integrin 
C-terminus bound to the SH3 domain, we employed transferred NOE (trNOE). This method is 
best suited to study weakly associating systems comprising of small ligands bound to large 
molecules. NOESY spectrum of β3 heptapeptide, collected in the presence of GST-fused SH3 at 
an optimized peptide to protein molar ratio of 200 to 1, demonstrates the additional peaks 
manifesting the binding (Fig. 3.11 (a)). These peaks were absent in the control experiment with 
GST alone. Although partial assignments for the bound heptapeptide were made, insufficient 
amount of distance restraints deterred us from obtaining the complete structure of the complex. 
As no medium-range NOEs characteristic for α-helical secondary structure were observed, we 
speculate that upon binding the peptide exists as an ensemble of random coil and extended 
conformers. The secondary structure of the heptapeptide was further probed by circular 
m-proxyl MTSL 
(a) 
(b) 
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dichroism (CD). The spectra showed a negative band at 197 nm and a positive band at 229 nm 
Fig. 3.11 (b), reflecting the presence of a left handed PPII helix. Molar ellipticities per residue 
for these two bands are somewhat weaker for β3 heptapeptide when compared to the values 
reported in literature for peptides adopting a polyproline type II helix conformation [41, 42]. This 
suggests that β3 heptapeptide might adopt a partial PPII type helical conformation. 
 
 
 
Figure 3.11 (a) Superimposition of the NOESY spectra obtained for β3 hepta-peptide alone 
(blue) and in the presence of GST-SH3 (red). (b) Circular dichorism spectrum obtained for 
β3 hepta-peptide shows a negative band at 197 nm and a positive band at 229 nm, typical for a 
partial polyproline type II-like helix. 
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Various models of β3 heptapeptide were generated (with or without C-terminal paramagnetic 
label attached) using the Haddock (High Ambiguity data driven protein–protein DOCKing) web 
server [43, 44] to investigate the binding of β3 heptapeptide to SH3 domain (PDB: 1SRL). The 
ambiguous interaction restraints (AIRs) were defined by NMR titration and PRE experiments 
with the starting conformation of the heptapeptide consistent with our trNOE and CD data. 
Cluster analysis of the resulting 200 water-refined models reveals 72% (with the paramagnetic 
tag) and 69% (without tag) of these models belong to a single cluster. Both clusters 
accommodate very similar binding interfaces as shown in the inset of Supporting Information 
Figure 3.8. The backbone root mean square deviation (RMSD) from the lowest energy model for 
the conformers from the cluster with tag is 1.1 Å, while for the conformers from the cluster 
without tag is 1.3 Å. 
3.5.4 Discussion 	
The initial events in β3 integrin outside-in signaling rely on its association with the SH3 domain 
of Src kinase. We have deduced the molecular details of this interaction using NMR. Chemical 
shifts mapping experiments depict the C-terminus of β3 located between the RT and n-Src loops 
of SH3 domain, with Y131 from the β4 strand serving as a bridge between the two. As per our 
PRE results, the RGT motif binds to the pocket formed by the n-Src loop. The preceding NITY 
motif makes occasional intermediate contacts with the RT loop rendering its conformational 
heterogeneity. 
The experimental data allowed us to obtain a reliable docked model of the complex using the 
HADDOCK web server. We are certain that our docking model provides a more accurate 
representation of the binding interface Fig. 3.12 (c) than the recent X-ray model (PDB: 4HXJ) 
containing the RGT tri-peptide [14] (Fig. 3.12(d)) for the following reasons: (i) We have used 
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the longer construct, full length β3 cytoplasmic tail, in addition to the heptapeptide. According to 
our model, the RGT motif binds to n-Src loop while the remainder of the β3 tail extends into the 
RT loop. The “fishing hook” arrangement presented in the X-ray structure, which places integrin 
on top of SH3, would not explain the conformational exchange in the RT loop observed in our 
titration experiments. Moreover, our CD data shows that the heptapeptide has a partial PPII 
helix, a characteristic feature of SH3 binding ligands, which tend to interact between the RT and 
the n-Src loops. (ii) We have attached the paramagnetic tag to the C-terminal end of RGT 
sequence, which allowed us to orient the RGT motif unambiguously with respect to its SH3 
binding pocket. If the orientation were to be as per the X-ray structure, we would have seen the 
PRE effect opposite to the current site on SH3's surface. Moreover, the weak electron density 
map, used to fit the small RGT tri-peptide, could easily lead to an ambiguous orientation. This 
ambiguity is further accentuated by the following two observations form the X-ray structure: the 
average B-factor for RGT is 67 Å2, much higher than that of the SH3 domain itself (13.5 Å2), 
and the asymmetric unit of the crystal structure containing two SH3 molecules binds to a single 
RGT peptide (Figure 3.13). (iii) Our model also supports the biochemical studies that have 
clearly shown the importance of R760 from integrin β3 YRGT motif and D117, W118, and 
Y131 residues from the SH3 domain. According to our model, the partial PPII characteristic of the 
peptide allows arginine side chain from the RGT motif to be positioned between the aromatic 
residues W118 and Y131 within the specificity pocket. This allows R760 to easily interact with 
either of the residues, while no such interactions occur in the X-ray model. Additionally, the 
guanidinium group of R760 forms a salt bridge with the side chains of either D99 or D117 or with 
both, as shown by some conformers of the ensemble, while in the X-ray model this crucial 
arginine exhibits predominantly hydrophobic contacts with a single backbone amide hydrogen 
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bonded to D117. (iv) Furthermore, the electrostatic surface potential of SH3, presented for the 
apo-domain in Figure 3.14(a) and for our model in Figure 3.14(c) provides a more plausible 
binding opportunity that is driven by polar interactions between the negatively charged groove 
on the SH3 surface and positively charged side-chain of R760, proving critical for the complex 
formation [14] and shown to enhance selectivity (as an R/Kxx or xR/K addition) when linked to 
PxxP, the canonical SH3 binding motif [33]. The surface potential for SH3 domain calculated 
based upon the coordinates from the X-ray complex (PDB: 4HXJ), presented in Figure 3.14(b), 
makes it electrostatically unfavorable to place the negatively charged carboxyl end of the peptide 
into the negatively charged groove on SH3. 
The X-ray structure of the inactive Src kinase (PDB: 2SRC) shows the linker connecting the SH2 
and the kinase domains in close proximity to the RT and n-Src loops of SH3 domain [16]. The 
question remains whether β3 binds to Src kinase in its inactive closed form in the presence of the 
linker, and, if so, how does the linker affects its affinity for Src kinase. Or, alternatively, β3 might 
bind to the open form, replacing the linker, thus preventing Src kinase from becoming inactive 
and maintaining a small population of active kinase partially poised to start the activation process 
induced by integrin microclustering. 
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Figure 3.12 (a) β3 heptapeptide docked onto Src SH3 domain using HADDOCK program. 
Chemical shift perturbations are mapped in purple. Additionally, the residue most affected by the 
spin label is shown in orange. (b) Electrostatic surface potential of SH3 domain bound to β3 
heptapeptide (colored with +6kT/e). (c) A ribbon representation of the binding interface obtained 
from the docked model highlighting R760 which could make potential contacts with either D99 or 
D117 in the specificity zone. (d) X-ray structure of the RGT peptide in complex with SH3 domain 
(PDB: 4HXJ) comparatively showing the reverse orientation of the peptide. 
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Figure 3.13 Electron Density for the RGT Peptide. The wire representation of protein is shown 
in green while peptide atoms are shown in yellow. (PDB: 4HXJ) 
 
 
 
Figure 3.14 The electrostatic surface (colored with +6 kT/e) of SH3 domain alone (pdb code: 
1SRL, panel a) and our docked model with integrin β3 heptapeptide (panel c) are mapped using 
the more rigorous Adaptive Poisson-Boltzmann Solver (APBS) with the electrostatic potential 
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energy calculated based on Poisson-Boltzmann equation. The X-ray model (pdb code: 4HXJ, 
panel b) is mapped using Coulombic Surface in an attempt to match its representation from the 
article. [14] 
 
In light of the proposed mechanism of outside-in signaling [18], where some integrin β3 
molecules are primed for activation of Src kinase, the weak binding as observed from our trNOE 
experiments seem pertinent. In addition, we have further investigated whether SH3 domain binds 
to the phosphorylated β3 and found no interaction, suggesting that Src can be associated with 
integrin through its SH3 domain only in the resting non-phosphorylated state of the receptor. We 
believe that this weak but constitutive interaction would keep Src tethered to the integrin and 
consequently bring two or more Src kinases to close proximity upon integrin activation via 
clustering [7]. This, in turn, would aid in trans-activation of the kinase through auto-
phosphorylation of Y418 in the Src activation loop. 
3.5.5 Conclusions 	
In conclusion, our chemical shifts mapping data in concert with PRE, trNOE and CD studies 
have confirmed the RGT762 motif of β3 integrin as the binding site for Src kinase. We have used 
these data to generate a reliable model of the complex through docking. Furthermore, we have 
shown that tyrosine phosphorylation of β3 cytoplasmic tail prevents it from binding to SH3, 
corroborating the reports of a constitutive interaction between resting integrin β3 and Src kinase 
[7]. 
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3.6 Identification and structural characterization of β3 integrin cytoplasmic 
tail as a binding partner of c-Src SH2 	
3.6.1 Overview 	
In resting platelets, Src forms a complex with αIIbβ3 integrin through the interaction involving c-
Src SH3 domain and the carboxyl-terminal region of the β3 cytoplasmic tail [7, 8, 14, 45]. When 
the platelets gets stimulated, as exemplified by phosphorylation of Y747 and Y759 (present within 
the β3CT), the activated β3 prevents its binding to the SH3 domain [45]. Interestingly, it was 
found that the activated β3 could still be bound to Src, making it catalytically active [15].  Based 
on the recent findings and our preliminary data, we hypothesized that phosphorylated β3 recruits 
SH2, the phosphotyrosine-recognizing domain of Src, which we believe regulates Src activation. 
Overall, our proposed work should serve as a foundation for structural understanding of integrin 
mediated Src activation with focus on Src SH2 domain as a central key regulatory element. 
The Src homology 2 (SH2) spans the region between the amino acids sequence 140- 250 in c-
Src. It consists of a central β-sheet flanked by two α-helices. It is known to bind to pYEEI motif 
with a strong affinity and can also bind peptides with two phosphorylated tyrosines [46, 47]. The 
phosphorylation of second tyrosine, although not essential, increases the affinity of the binding 
peptides. The phosphotyrosine binds into a deep pocket formed near the central sheet of SH2 
domain, while the residues, C-terminal to the phosphotyrosine, bind to the region composed of 
C-terminal residues of SH2. This region comprises of a hydrophobic pocket that binds to the 
hydrophobic residues in Y+3 position, conferring specificity to the peptides that bind Src SH2 
domain [48].  
3.6.2 Methods 	
Expression and purification 
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β3 was expressed and purified as previously [3]. Two mutants of β3 (Y747F and Y759F) were 
prepared using Quikchange site directed mutagenesis kit. Tyrosine phosphorylation of β3CT and 
its mutants was achieved in vitro by using Src kinase, as described by Anthis et al [49], and is 
briefly described in next section. The Src SH2 domain (residues 143-245) containing pET28 
SacB AP vector, generously provided by Pawson lab, was expressed in BL21 (DE3) cell line. 
Purification of Src SH2 domain is performed according to the protocol from QIAGEN under 
nondenaturing conditions followed by gel-filtration on HiLoad 16/60 Superdex 75 column in 
20mM MES, 50mM NaCl, 1mM DTT buffer at pH 6.0. Cultures are grown in minimal media 
with 15NH4Cl as the sole nitrogen source.  
Phosphorylation of integrin tails by Src kinase 
We used a similar protocol as described by Anthis et al [49]. Briefly, Src and β3 were added at a 
ratio of 1:75 and the phosphorylation was performed overnight (~16hours) at RT in 50 mM Tris 
pH 7.3, 20 mM MgCl2, 10 mM MnCl2, 2 mM ATP. Phosphorylated tails were separated from 
unphosphorylated tails by HPLC and were identified by mass spectrometry (Figure 3.15) and 
NMR. 
 
Figure 3.15 MS spectrum of β3 integrin tails by Src. The largest peak represents the bis-
phosphorylated β3; NP (Non phosphorylated, MW of 7739); MP (mono-phosphorylated, MW of 
7819 including the additional 79 Da due to single phosphate moiety); and BP (bis-
phosphorylated, MW of 7899 with additional 158 Da due to double phosphate groups). 
 
NP 
MP 
BP 
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NMR sample preparation 
The heteronuclear NMR experiments were performed on uniformly 15N-labeled 0.1mM Src SH2 
samples (unless mentioned otherwise), with or without binding partners (β3CT BP full length / 
β3CT Y747F and Y759F and their phosphorylated versions/β3 derived phosphorylated peptide) at 
different concentrations on Varian Inova 600 MHz equipped with inverse-triple resonance cold 
probe at 30°C. The samples were prepared in pH 6 (unless mentioned otherwise) in the SEC 
buffer as above, with 10% D2O and 1mM DSS acting as an internal standard. Similar 
experiments were carried with non-phosphorylated β3CT as a control. 15N-HSQC titrations were 
also performed by titrating non-labeled Src SH2 into 15N-labeled phosphorylated β3 CT, to 
confirm binding from both sides. All the NMR data was processed by nmrPipe and analyzed by 
CCPN software suite. The structure of apo v-Src SH2 has been solved with NMR (BMRB 
accession: 6503) [50]. Using similar buffer conditions we were able to transfer about ~70% of 
assignments. Chemical shift assignments for β3BP were obtained from the previous studies 
performed by our lab [51]. 
3.6.3 Results  	
Through NMR binding studies, we demonstrate that SH2 domain of Src can interact with bis-
phosphorylated β3CT. Phosphorylation of β3CT was achieved using a previously reported in vitro 
assay and confirmed using MS. Bi-phosphorylated tail was further separated using reverse phase 
HPLC. 15N-labeled β3BP was titrated with NL Src SH2 at 1:1, 1:3 and 1:5 ratio of β3BP to Src 
SH2 (Figure 3.16). The signals from residues 747pYKEATST753 and R760 were broadened while 
G761 showed chemical shift perturbations (Figure 3.17). On the contrary, pY759 showed minimal 
perturbation. Additionally, control experiments with 15N-β3NP showed no such effect.  
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Further insights about the binding of β3BP to the Src SH2 domain were obtained by recording 
15N-HSQC spectra of Src SH2 in the presence β3BP and its (YtoF) mutants. Increasing 
concentration of β3BP when titrated into 15N-labeled Src SH2 domain showed reproducible and 
consistent chemical shift perturbations pattern at 1:1, 1:3 and 1:5 ratio, as shown in Figure 3.18. 
Additionally, we observed peak broadening effect in HSQC spectra, and few peaks disappeared 
completely. The associated chemical shift perturbations and broadened peaks were monitored 
and when mapped on the surface of the known structure (pdb: 1HCS) formed a continuous 
binding region onto the surface of SH2 (Figure 3.19).   
Furthermore, we phosphorylated two different mutants, β3 Y747F and β3Y759F, and studied the 
effect of mono-phosphorylated β3 on the binding pattern. Despite some subtle differences in the 
chemical shift perturbation pattern, the spectral analysis of Src SH2 in the presence of β3 Y759F 
(MP) showed a similar peak broadening effect as wild type (Figure 3.20 a). On the other hand, 
addition of β3 Y747F (MP) resulted in spectral changes, whereby the peaks, which were 
broadened in wild type, now either reappeared or exhibited perturbations when compared with 
the spectra of apo Src SH2 (Figure 3.21 b). These results indicate that the presence of second 
phosphorylated tyrosine is not entirely essential, however, it may improve the overall binding of 
integrins to SH2 domain. 
Additionally, we also performed ITC experiments using a peptide corresponding to bi-
phosphorylated integrin (RAKWDTANNPLpYKEATSTFTNITpYRGT762) as the titrant. We 
reached saturation within a few initial injections, thus further optimization is required to obtain a 
correct estimation of dissociation constant and other thermodynamic parameters.  
 
		43	
               
Figure 3.16	The superimposition of 15N-HSQC spectra of β3BP (shown in black) in the presence 
of varying molar excess of Src SH2 as shown in blue (1:1), green (1:3) and red (1:5). 	
pY747 
pY759 
1:0 
1:1 
1:3 
1:5 
β3BP+SH2 
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Figure 3.17	Chemical shift differences in β3CT HSQC spectra upon SH2 binding at 1:5 molar 
ratio. The asterisk mark represents proline and overlapping residues. The x represents weak 
intensity signal in apo form, thus not included in analysis.  
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Figure 3.18 The superimposition of 15N-HSQC spectra of Src SH2 (shown in black) in the 
presence of β3 BP at 1:5 ratio (red).  
 	
1:0 
1:5 
SH2 + β3 BP 
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Figure 3.19	Chemical shift differences in 15N Src SH2 spectra upon β3 BP binding at varying 
ratios (Green 1:1, blue 1:3 and red 1:5 molar ratio. Delta (ppm) refers to the combined HN and N 
chemical shift changes according to the equation: Δδ(HN,N) = ((ΔδHN2 + 0.2(ΔδN)2)1/2, where 
Δδ = δbound − δfree. The inset shows the chemical shift differences and broadened peaks 
(obtained from 1:5 ratio) mapped onto the surface of SH2 domain (PDB: 1HCS). 
 
 	
Figure 3.20 (a) The superimposition of 15N-HSQC spectra of Src SH2 (shown in black) in the 
presence of β3 Y759F (MP) (green) (b) The superimposition of 15N-HSQC spectra of Src SH2 
(shown in black) in the presence of β3 Y747F (MP) (blue). The 15N-HSQC spectra of Src SH2 in 
the presence of β3 BP (red) is shown for comparison.  	
1:1 
1:3 
1:5 
SH2 
SH2 + β3MP 
SH2 + β3BP 
SH2 
SH2 + β3MP 
SH2 + β3BP 
(a) (b) 
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3.6.4 Discussion 	
The amino acids sequence following the phosphotyrosine residue play a vital role in defining the 
specificity of the peptides binding SH2 domain [52]. The pYEEI, a high affinity peptide has an 
optimal sequence for SH2 binding whereby residue Ile at +3 position sits into the hydrophobic 
pocket [48]. Integrin β3 has two tyrosines present within its cytoplasmic tail, having pYKEATS 
and pYRGT motifs. Owing to the presence of a glutamate at +2 position (similar to YEEI) and 
alanine, a hydophobic residue at +3 position of the pY747, we believe SH2 preferentially binds to 
it and allows it to sit into the phosphotyrosine-binding pocket of SH2. 
Recently, Wu et al reported that activated β3 remain bound to c-Src, subsequent to which there is 
an increase in Src activity [15]. We, for the first time, identified the role of SH2 domain in 
binding to activated β3, characterized by phosphorylation of Y747 and Y759. It is imperative to 
further study the molecular and structural details of this interaction in signaling pathway, and 
within the more complex cellular context. 
In resting state, the intramolecular interaction between SH2 domain and pY527 bearing C-
terminal tail of the kinase domain, maintain Src in a closed conformation [18]. Although, the 
sequence of events involved in β3 mediated Src activation remains unclear, Src kinase activation 
has been achieved by disrupting this relatively weak interaction by using high affinity 
phosphopeptides [53]. On similar lines, we believe that phosphorylated β3 can displace pY527 
from SH2, thereby activating Src. It is logical to reason that binding of β3 can directly displace 
pY527 or it may affect the dynamics/conformation of SH2, and ultimately increasing the kinase 
activity. Further experiments are needed to investigate the role of β3 in displacing pY527. 
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3.7 Conclusions and Future directions 	
Because the SH2 domain is a known phosphotyrosine-recognizing domain, we tested the ability 
of the phosphorylated β3 to interact with the SH2 domain of c-Src. These results demonstrate that 
the phosphotyrosines and its adjacent residues are critical in mediating interaction between the 
SH2 domain and integrins. However, further experiments are necessary to confirm and 
characterize the interaction. In addition, we are proposing to utilize Nanodiscs, a discoidal 
nanolipoprotein with a phospholipid bilayer covered by an amphipathic protein coat. Nanodiscs, 
incorporated with and without phosphorylated β3 will be titrated into 15N-Src SH2 to study the 
interaction under membrane mimetic conditions. 
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Chapter 4. Binding and Backbone Dynamics of Protein under 
Topological Constrain: Calmodulin as a Model System 	
4.1 Introduction  
Over the last twenty years, hundreds of cyclized proteins (i.e., N- and C- termini linked 
together), have been identified in nature and implicated in a wide range of biological activities 
[1, 2]. Owning to their unique folding topology, circular proteins show remarkable thermal, 
chemical, and enzymatic stability [3, 4]. A few cyclic derivatives of polypeptides and larger 
proteins have been developed using various methods [4-6], resulting in enhanced resistance 
toward denaturation and proteolysis when compared with their linear counterparts. While much 
progress has been made in elucidating the structure and corresponding biological activities of 
circular proteins [7, 8], the physical basis of how the circular topology modulate the functions of 
proteins (e.g., molecular recognitions) remain elusive. Particularly, how does the topological 
constrain affect the protein’s internal dynamics and subsequently, their thermodynamic 
properties. It is conceivable that the circularization of a protein with flexible ends may reduce its 
conformational entropy. Since the changes of protein conformational entropy are potentially 
linked to the free energy of protein-ligand association, the circularization may change the 
binding affinity of the protein to its receptor. Herein, we attempt to understand the effect of 
circularization on protein dynamics and molecular recognition using calmodulin (CaM) as a 
model system.  
The use of CaM as the model system is based on the fact that it is an extensively studied protein 
known to interact with a variety of target proteins involved in many aspects of cellular function 
[9]. CaM is composed of two, N- and C-, globular lobes, each containing a pair of helix-loop-
helix motifs (EF-hands) that bind calcium ions. When bound to four calcium ions, CaM	adopts	a	
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dumbbell configuration comprising of two lobes tethered by a central flexible linker (Figure 4.1 
(a)) [10, 11]. Upon binding to target proteins, the flexibility of the central linker (residues 78–81) 
allows the two lobes to adjust their relative orientation, resulting in the collapse of CaM into a 
more rigid globular fold (Figure 4.1 (b)) [12]. This mechanism is sometimes referred to as the 
wrap-around mode of binding [12, 13]. Since CaM undergoes a large conformational change 
upon binding, we wanted to investigate whether cyclization affect the binding and dynamic 
behavior of calmodulin. 
                      
Figure 4.1 (a) NMR structure of Calmodulin. The N- and C-lobe are connected by the central 
linker (b) NMR structure of the complex of Ca2+-CaM with the smMLCK peptide. The N- and 
C-lobe wraps around the smMLCK peptide (red helix) (PDB: 2K0F). 
 
We investigated CaM interactions, in its linear and artificial cyclized forms, with its natural 
ligand by isothermal titration calorimetry (ITC). We found that the cyclization affects the 
enthalpy of calmodulin binding to its ligand, which is compensated by a favorable change in the 
entropy of calmodulin binding to its ligand, although the overall binding affinity of interaction 
remains the same. Since the conformational entropy of proteins is manifested as the motion 
between different structural states, characterization of protein dynamics provides a means to 
measure conformational entropy. Thus, we use nuclear magnetic resonance spectroscopy (NMR) 
(a) (b) 
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to compare the backbone dynamics of the CaM constructs in both the linear and circularized 
states. We observed a small reduction in the flexibility of CaM, which may contribute to the 
lower conformational entropy. The effect of cyclization was more pronounced in the C-lobe with 
a slight increase in rigidity of the central loop.    
4.2. Experimental Section 
Expression and purification 
	
The gene encoding modified CaM was ordered from GenScript, in which the His6-tag, thrombin 
cleavage site and a peptide sequence (LCTPSR) were placed at the N-terminus of calmodulin 
(residues 2-149, Uniprot P62161). Another similar peptide sequence (LCTPSR) was placed at 
the C-terminus just before the stop codon. The gene was inserted into the pET-28b vector 
(Novagen) between the NcoI and XhoI restriction sites. The resulting plasmid was -transformed 
in the BL21(DE3) cells (Invitrogen). The cells were incubated in LB media with kanamycin with 
shaking at 37°C until OD600 = 0.6. The temperature was lowered to 18 °C, and 100 µM IPTG 
was added to induce expression of the CaM. The cells were harvested by centrifugation after 12-
16h. His6-tagged CaM was purified using Ni-agarose resin (Thermo Scientific) in Tris buffer, pH 
8, 300mM NaCl. Purifed CaM was then eluted using a concentration gradient of imidazole 
(concentration ranging from 5mM to 1M). Eluates were subjected to SDS-PAGE analysis and 
fractions containing CaM were pooled and extensively dialyzed using 20mM Tris, pH 8. The 
dialyzed sample was further purified using anion exchange chromatography (Resource Q) and 
the peak corresponding to CaM was further purified through HiLoad 16/60 Superdex 75 column 
(GE Healthcare) equilibrated with 100mM KCl, pH 6.3.  
Isothermal Titration Calorimetry (ITC) 
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Isothermal titration calorimetry was performed on a low volume Nano ITC, manufactured by TA 
instruments, USA. The (smMLCKp) peptide ARRKWQKTGHAVRAIGRLSS, corresponding to 
the calmodulin binding region of smooth muscle myosin light chain kinase, was synthesized by 
Applied Biosystems, Inc., and further purified by reverse phase HPLC. All experiments were 
carried out in 20 mM phosphate buffer, pH 6.3, 100 mM KCl, 6.1 mM CaCl2 at 35°C with a 
stirring speed of 200 rpm. Each titration consisted of twenty 2.5 µl injections with 300 s time 
intervals. As a control, the heat of dilution was also measured by injecting peptide into buffer 
solution containing no CaM. The heat of binding was obtained as the difference between the heat 
of reaction and the corresponding heat of dilution. Data analysis was done in NanoAnalyze 
Software suite using an “independent” model. In all cases, a stoichiometry of 1 ± 0.1 was 
revealed. 
Differential scanning calorimetry (DSC) 
The purified linear and cyclic CaM at concentrations of 0.3 mM were used for the experiments. 
The samples were referenced against the buffer obtained as a filtrate from the concentration step. 
Prior to the run, the samples were degassed using vacuum degasser. Thermograms were obtained 
by scanning from 10 to 130°C at 1°C/h (scanning rate) at a constant pressure of 3 atm. In total, 
three sets of heating, cooling cycles were done using NanoDSC (TA Instruments, USA). The 
data was corrected for baseline with a thermogram obtained from the buffer scans. 
NMR Spectroscopy 
To produce 13C and 15N   isotopically labeled CaM, cells were grown in M9 minimal media 
containing 13C glucose (2.5g/ltr) and 15NH4Cl (1.1g/ltr) as the sole source of carbon and nitrogen. 
NMR samples were prepared as described in Barbato et al [11]. Briefly, a 1mM CaM was 
prepared in 95% H2O/5% D2O, 6.1mM CaCl2, and 100mM KCl, pH 6.3. The backbone 1H, 13C, 
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and 15N resonances were assigned based on triple-resonance experiments: HNCA, HNCO, 
HNCACB, HN(CO)CA, HN(CA)CO and CBCA(CO)NH, collected using Varian/Agilent 
BioPack sequences.  
Heteronuclear–15N NOEs, longitudinal (R1), and transverse (R2) 15N relaxation rates were 
measured using standard two-dimensional methods [14]. Steady-state hetero-nuclear 1H-15N 
NOE values were determined from spectra recorded with 3s relaxation delay and in the presence 
and absence of a proton presaturation period of 4s. 15N-T1 values were measured from the 
spectra recorded with 7 different durations relaxation delays of T= 0.03, 0.08, 0.14, 0.3, 0.5, 0.85 
and 1ms. 15N-T2 values were determined from the spectra recorded with 7 different durations of 
the delay: T= 0.01, 0.03, 0.05, 0.09, 0.13, 0.170 and 0.25ms. T1, T2 and NOE values were 
extracted by a curve-fitting subroutine included in the CCPN software suite[15]. All experiments 
were performed at 35°C on 600 MHz magnet (Agilent, USA) equipped with inverse-triple 
resonance cold probe. All spectra were processed with NMRPipe [16] and analyzed by CCPN 
software suite. The generalized order parameter (S2) was obtained using the FAST-modelfree 
program [17]. 
4.3 Results 	
4.3.1 CaM Constructs Design and the Evidence of Cyclization 
 
We added a sequence (LCTPSR) at both the N- and C-termini of calmodulin, which appeared to 
be sufficient for the formation of disulfide bond between the two cysteines (Cys) to facilitate the 
cyclization of the protein (Figure 4.2 a). CaM circularization, via the oxidation of the two 
introduced Cys occurred spontaneously during the purification process. Examining the protein by 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) shows that the CaM 
existed in a circular form in solution, with the N- and C- termini connected (Lane 5 in Figure 4.2 
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b). The disulfide link is stable against the temperature changes up to 95˚C (Lane 7). The reduced 
counterpart is only obtained by adding β-ME with simultaneous heating the protein (Lane 8). 
The CaM in its cyclic form (c-CaM) is well separated from the reduced form in the SDS-PAGE 
as the result of the changes in its electrophoretic mobility by circularization. The electrophoretic 
mobility of the linear CaM (l-CaM), where cysteines have been mutated to alanines, is shown in 
lanes 1-4 and resembles that of the reduced c-CaM (Lane 8). The molecular weights of cyclized 
and linear CaM were measured using MS and the presence of disulfide linkage within c-CaM 
was confirmed by MS/MS.  The thermal stability of the calcium saturated linear and circular 
CaM were examined by Differential scanning calorimetry (DSC). Though we were able to 
estimate the transition temperatures, Tm, complete analysis of the calorimetric data was not 
performed owing to the limitations with data fitting at higher temperatures. The transition 
temperatures of linear and cyclic CaM were found to be similar, 113˚C and 114˚C respectively 
(Figure 4.3), demonstrating high thermal stability for both the constructs. Interestingly, in 
addition to the major peak the melting curve of c-CaM, depicts an additional shoulder peak at 
95˚C. We speculate that this peak arises from the breakage of the disulfide bond present within 
the cyclic CaM and may reflect the separation of N and C domains. However, the overall thermal 
stability of CaM is not significantly affected upon cyclization, which is not extraordinary owing 
to the resistance of CaM to heat denaturation in calcium-loaded state [18].  	
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Figure 4.2 (a) Scheme for CaM cyclization showing the additional peptide sequence added to 
facilitate disulfide bond formation, and (b) CaM migration patterns on SDS-PAGE gel under 
different sample conditions. Control represents Linear CaM where both the Cys are mutated to 
alanine. 
 
 
 
             Figure 4.3 DSC thermograms of linear calmodulin (blue) and cyclic CaM (red) 
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4.3.2 Molecular recognition  
We used ITC to study the interaction of calcium-saturated linear and cyclic CaM constructs with 
its well established ligand, a peptide representing the calmodulin-binding domain of the smooth 
muscle myosin light chain kinase (smMLCKp). Figure 4.4 presents binding isotherms at 35°C 
for the linear (Figure 4.4 a) and cyclic (Figure 4.4 b) forms of the protein, respectively. Changes 
in the Gibbs free energy (ΔG) for the formation of CaM-peptide complex, and the contributions 
from enthalpy (ΔH) and entropy (-TΔS) derived from the isotherms are shown in Figure 4.4 c. 
Binding of smMLCKp to l-CaM is dominated by a large favorable change in the binding 
enthalpy, which compensates the unfavorable change in the binding entropy. Upon cyclization, 
the enthalpy term is significantly reduced. However, the associated loss in the overall binding 
enthalpy is compensated by the change in the entropy term, converting it from unfavorable to a 
favorable factor promoting the interaction. Thus, the overall ΔG of ligand binding remains very 
similar between the two constructs (Table 1). 
 
Thermodynamic 
Factor 
Linear CaM  
(kJ/mol) 
Cyclic Cam  
(kJ/mol) 
ΔG -39.24 -39.46 
ΔH -57.04 -15.06 
-TΔS 17.8 -24.4 
 
Table 4.1 Thermodynamic profiles of smMLCK peptide binding to linear and cyclic Calmodulin.  
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Figure 4.4 Traces of the calorimetric titration and the binding isotherms obtained for (a) l-CaM 
and (b) c-CaM with peptide ligand, smMLCKp, at 35 °C (c) Comparison of the thermodynamic 
origins for smMLCKp binding to the l-CaM and c-CaM.  
 
 
 
 
 
 
 
 
 
 
 
(a) (b) 
(c) 
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Binding of calcium-saturated linear and cyclic CaM was also compared using chemical shifts 
mapping experiments, through 15N-HSQC spectra, where non-labeled smMLCK peptide was 
titrated into 15N-labeled CaM. This titration was performed at CaM to smMLCKp molar ratios of 
1:2 at a pH 6.3. The chemical shift perturbations observed for our modified l-CaM construct 
(Figure 4.5) are consistent with CaM binding to smMLCK peptide previously observed [11]. The 
effect was similar for c-CaM construct (Figure 4.5), suggesting that the topological constrain did 
not impede the formation of a collapsed globular structure of CaM in the presence of smMLCK 
peptide.  
 
 
Figure 4.5 The superimposition of 15N-HSQC spectra of linear CaM (shown in green) and cyclic 
CaM (blue) in the presence of smMLCK at a ratio of 1:2. 
 
 
 
Linear CaM + smMLCK 
Cyclic CaM + smMLCK 
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4.3.3 Backbone Dynamics  
To assess the backbone dynamics of c-CaM and l-CaM we used 15N relaxation experiments 
(Figure 4.6). The amide 15N relaxation rates, R1 and R2, and the steady-state heteronuclear 15N 
{1H} NOEs are influenced by the local backbone dynamics on a time scale ranging from 
picoseconds to nanoseconds [14]. The order parameter (S2), which describes the amplitude of 
fast motions experienced by the individual NH bond vectors, was obtained using Model-free 
approach for l-CaM and c-CaM (Figure 4.7 (a) and 4.7(b)[17]. High S2 values, approaching 1, 
indicate limited motions and greater rigidity, whereas lower values indicate larger amplitude of 
motions and more flexibility [11]. The residues showing spectral overlap in the 15N-HSQC and 
those associated with erroneous values in Model-free fitting (error >10%) were omitted from the 
relaxation analysis. As shown in Figure 4.7, the S2 values were very similar for the N–terminal 
domain and for most of the residues within the C-lobe. Although we expected a greater rigidity 
of the central helix, we observed only a slight reduction in the mobility of the central linker 
residues upon cyclization. In comparison to the linear CaM, the loops present within the C-lobe 
of the cyclized form experience a considerable loss in their flexibility, possibly due to their 
proximity to the cyclization site.  
 
 
 
 
 
 
 
 
		64	
 
Figure 4.6 (a)-(c) Comparison of the 15N    relaxation time, T1, T2, and heteronuclear NOE 
measured at 600 MHz for the linear CaM and cyclic CaM. 
 
 
(a) 
(b) 
(c) 
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Figure 4.7 Plots of the order parameter (S2) values with respect to residue number of (a) l-CaM 
and (b) c-CaM. S2 values are calculated using FAST model free software using R1, R2 and NOE 
relaxation data [17]. 														
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4.4 Discussion 
The concept of protein cyclization has been increasingly appreciated as cyclic variants exhibit 
higher thermal stability and resistance to proteases, thus resulting in an overall better stability of 
potential biologicals. Different strategies towards this ultimate goal have adopted from the ones 
employed by nature and/or designed de novo. In particular, adding cysteine containing short 
peptides to the N- and C-termini have been found successful in circularization of the protein 
without affecting its overall fold and biological activities [6]. Similarly, we were able to obtain a 
cyclic protein by introducing cysteine-containing sequence (LCTPSR) at the N- and C- termini 
of the protein. Since wild type calmodulin does not bear native cysteine residues [19], the 
formation of a disulfide bond only occurred between the two cysteines we incorporated at the 
extensions of the N- and C-termini. Previous studies by Tan et al, demonstrated the abrogation of 
nanomolar (nM) binding affinity of CaM to its ligand, when cysteine mutations were introduced 
within the structure of CaM [20]. In contrast, the modified -CaM used in the present study, 
maintained its binding profile with the smMLCK peptide, though the dissociation constant (Kd) 
is only slightly increased (from few nanomolars to hundreds of nanomolars).  Thus, our modified 
versions of CaM constructs mimic the native system with minimal perturbations in its three-
dimensional conformations. 
According to the previous calorimetric studies, interactions of CaM with different peptides are 
usually driven by a large favorable change in enthalpy [21]. However, in some cases the 
enthalpic term is also accompanied by a favorable change in entropy [9].  Thus, the binding 
interface of calmodulin is thermodynamically fluid and has been a subject of wide interest and 
extensive investigations in the field [10, 21-23]. Our ITC results indicate that the backbone 
cyclization of CaM results in an enthalpic-entropic compensation, and, thereby, shifting the 
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enthalpy driven process to, largely, the entropy driven interaction. As conformational entropy of 
backbone residues can be assessed using the established relationship of NMR-derived order 
parameter and entropy [24], we used NMR spectroscopy to study the relaxation properties of the 
circularized CaM. 
The 15N relaxation data allowed us to calculate S2, the order parameter representing the degree of 
flexibility. The S2 values obtained for the residues of linear CaM follow the same trend as the 
ones of the wild type (wt) CaM, though the average absolute values are slightly higher due to 
increase in the size of our constructs. The l-CaM has S2 value of 0.94 for the N-terminal domain 
and 0.89 for the C-terminal domain.  However, for the cyclized CaM, the values for N- and C-
terminal domains were found to be 0.95 and 0.94, respectively. This is indicative of a reduction 
in flexibility of C-terminal domain of calmodulin upon cyclization. Previous studies by Barbato 
et al on wt CaM have shown that the N- and the C-domain of CaM behave isotropically while 
the residues in the central helix exhibit a high degree of flexibility [11]. Due to the bigger size of 
our constructs, the S2 values for l-CaM and C-CaM are on the upper limit, restraining our ability 
to calculate conformational entropy using the classical approach.  
It appears that C-lobe of l-CaM possesses greater backbone mobility, which is considerably 
reduced upon cyclization and may get further reduced upon binding to the smMLCKp. Thus for 
c-CaM, the reduced backbone mobility may confer entropic advantages to the ligand binding. On 
the other hand, the linear counterpart experiences a strong network of hydrogen bonding (as 
indicated by enthalpy change) while at the same time; it has to undergo a tremendous 
conformational change to form a compact structure. The total change in entropy also entails the 
contribution from side chains as upon binding to smMLCK peptide, the side chains of wt CaM 
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has been shown to exhibit a range of motion[25], while the backbone dynamics of wt CaM gets 
minimally perturbed.  
4.5 Conclusions and future directions 
CaM, a calcium modulated protein was modified using a disulfide linkage. A subtle change in 
the structure was enough to alter the enthalpy-entropy contributions, however, it was remarkable 
to observe that the free energy remain constant. To further qualify these changes, we studied the 
backbone dynamics of CaM. Despite the conformational change of the protein, the flexibility of 
backbone residues weren’t significantly affected. Previous studies identified that dynamics of 
side chains (of wt-CaM) contribute significantly to the binding of smMLCK. It would be useful 
to study the dynamics of side chain residues and identify the factors contributing to the enthalpy-
entropy compensation. Besides, one can also perform H-D exchange experiments in apo and 
bound forms to study the effect of solvation that contributes significantly to the entropy term.  
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Chapter 5. Conjugation study of engineered cellulase with end 
functionalized polymers 
 
The chapter is written in the ‘Methods’ style.  A	version	of	Chapter	5	is	under	preparation	for	publication.	 
5.1 Introduction 
 
The field of chemical biology has recently been surged with designer catalytic machines, 
comprising of functionally active enzymes combined with synthetic polymeric scaffolds [1, 2]. 
The combination, typically called bioconjugates, has been increasingly used in biotechnology 
and biomedical research for widespread applications [1, 3-5]. Several methods have been 
employed to prepare protein-polymer conjugates, which include direct labeling of free reactive 
thiol or amine groups, incorporation of unnatural amino acids, or use of enzyme-based 
modifications [6, 7]. Amongst an array of enzyme based protein-polymer conjugation 
techniques, a highly selective approach is to fuse the protein of interest to enzymatic 
domains/tags that can covalently conjugate with different chemical reporters [1, 5].  
The strategy of using enzyme based covalent functionalization of proteins confers many 
advantages [7]. It is particularly attractive because the labeling can be controlled at the site of 
enzymatic catalysis, resulting in formation of highly specific, efficient and stable covalent 
adducts. Being selective and irreversible in nature, the complexes formed, evades the need for 
additional purification and do not require subsequent separation steps [8]. Other advantages 
include the use of a range of end-functionalized polymers having different scaffolds, and the use 
of milder conditions as compared to other chemical reactions. Since direct labeling of target 
protein may lead to functional loss, labeling through additional enzymatic tags provides 
successful alternate route. The challenge associated with the use of such fusion proteins is to 
express the protein of interest without interfering its native activity. Recombinant DNA 
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technology, which involves manipulation of DNA at molecular level, alongwith rational design 
of the fusion construct have provided effective solutions in expressing engineered proteins that 
maintain their functionality [9].  
In our current study, we have used two most prevalent enzymes, namely Cutinase, and human 
O6-alkylguanine-DNA alkyl transferase (hAGT), referred as SNAP-tag, that can be self-
modified to achieve labeling with differently functionalized polymers [10, 11]. The cutinase-tag 
is a 22kDa serine esterase, consisting of Ser-His-Asp catalytic triad [12]. The catalytic serine 
residue forms a covalent complex with the phosphonate-functionalized molecules/polymers [13]. 
On similar lines, SNAP tag, a 21kDa alkyl transferase, can irreversibly react with benzyl-guanine 
derivatives. The enzyme transfers the benzyl group from O6-benzylguanine derivatives to its 
active cysteine residue to form highly specific covalent adducts [11, 14].  
We constructed two different fusion proteins comprising of cutinase tag and SNAP tag 
respectively, with our target protein, Cel48F (family 48), an important enzymatic member of 
Clostridium cellulolyticum cellulosome [15]. A cellulosome (shown in Figure 5.1) is a multi 
enzyme unit comprising of a non-catalytic protein scaffold to which many cellulolytic enzymes 
(cellulase) bind to organize into a supramolecular array of protein-enzyme complex [15, 16]. The 
cellulolytic enzymes act in concert to catalyze the conversion of cellulose to glucose. This 
catalytic conversion is of considerate importance in biofuel industry, as the resultant sugars can 
be further fermented into fuel alcohol [17].  
Considering the biotechnological significance of the cellulolytic enzymes and inspired by the 
hydrolytic efficiency of natural cellulosomes, we are interested in creating artificial cellulosomes 
by replacing the protein scaffold with the polymeric scaffold, to which various cellulases can be 
conjugated.  
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Figure 5.1 A cellulosome assembly. The enzymatic unit consists of a catalytic domain of 
cellulase enzyme, a non-catalytic carbohydrate binding module (CBM) and a dockerin unit. The 
scaffoldin is a non-catalytic unit comprising of cohesins that bind to Dockerin to form a 
cellulosome assembly. Cel48F enzyme used in our studies lacks the CBM. The figure is taken 
from Fontes, C.M. et al., Annu Rev Biochem, 2010 [15]. 	
Taken together, we present a method to prepare functionally active Cel48F-cutinase engineered 
protein that can be site specifically linked with phosphonate-functionalized polymers (Figure 
5.2). In addition, we also present the preliminary results of a differently tagged cellulase, namely, 
Cel48F-SNAP that can covalently bind to benzylguanine derivatives (Figure 5.2).  By precisely 
controlling the number of functional groups on the polymeric scaffold, we can fine-tune the 
number of cellulase enzymes being conjugated on to the polymer. The advantages associated 
with this approach are its modular nature and the flexibility of decorating the polymeric scaffold 
with different functional groups. Here, we have developed a general route to site-specifically link 
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enzymes to bi-functionalized polymer scaffolds via bioorthogonal chemistry. Our long-term goal 
is to employ a similar strategy to other members of cellulases and prepare supramolecular 
assembly that mimics the natural cellulosome.  
 
 
Figure 5.2 (a) Labeling of Cutinase tagged fusion protein with phosphonate derivatives. (b) 
Labeling of SNAP tagged fusion protein with benzylguanine derivatives.  
 
5.2 Materials 
 
Equipment: Heating block (Fisher Scientific Isotemp 125D), Incubator (New Brunswick 
Scientific), Benchtop mini centrifuge (Fisher Scientific accuSpin MicroR), 1.5 microcentrifuge 
tubes, 50ml falcon tubes, French Press, AKTA system (Amersham Biosciences), Magnetic stir 
bar, Stirrer, Gel electrophoresis apparatus, Gel imaging system with BioRad GelDoc system, 
(a) 
(b) 
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Spectrophotometer, nutator mixer (Labnet Rocker 25), Micropipettors, Pipettor tips, dialysis 
bags, clips, precast gels, 1ml cuvettes, amicon filters.  
Reagents: Kanamycin, agar plates, IPTG, lysozyme, terrific broth Modified EZmix powder 
(Sigma), glycerol, Tris base, Tris maleate, sodium chloride, imidazole, calcium chloride, DTT, 
2x Laemmli Sample Buffer (Bio-Rad Catalog #1610737), electrophoresis buffer, Avicel (PH101, 
Fluka, Buchs, Switzerland). Origami B (DE3) chemically competent cells were purchased from 
EMD Biosciences. Ni-NTA agarose was purchased from Qiagen. Complete-Mini EDTA-free 
protease inhibitor tablets were purchased from Roche Applied Science.  
5.3 Methods 
 
5.3.1 Molecular cloning of fusion proteins 
 
The Cel48F-Cutinase plasmid was constructed from Cel48F plasmid, synthesized by GenScript 
Corporation. The restriction site for SalI was introduced by PCR. The resultant product was 
ligated with the DNA coding for the cutinase insert (amplified from previously constructed 
plasmid). The gene encoding Cel48F-linker-cutinase protein was then cloned into pET26b vector 
via NdeI and XhoI, resulting in Cel48F-Cut plasmid. pET26b(Cel48F-SNAP), was generated by 
replacing cutinase domain with SNAP domain between HindIII and XhoI. However, the resultant 
plasmid had a shorter linker than Cel48F-Cut plasmid.  
Transformation of Cel48F plasmids 
1. Set the heating block to a temperature of 42 °C.  
2. Thaw 50ul of E.coli cells (Origami2 (DE3) strain). Add 2ul of plasmid (10-50ng) to 50ul of 
cells and incubate in ice bath for 30 minutes.  
3. Heat at 42 °C for 45s, immediately incubate in ice for 2minutes. 
4. Add 400ul of LB and incubate at 37 °C for 45-60 minutes. 
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5. Centrifuge the eppendorf tube for 2minutes. 
6. Discard the media, resuspend in 50ul of media.  
7. Plate the transformation reaction on LB-agar plate supplemented with kanamycin (50ug/ml) 
for 16-18 hours at 37 °C.  
5.3.2 Expression and purification 
 
Expression:		
1. Pick a single colony from the agar plate, and suspend it in 50ml TB broth having kanamycin 
(50ug/ml) antibiotic. Allow it to grow for 12-16 hours at 37 °C with shaking at 225rpm. 
This is referred to as seed culture. 
2. Inoculate 1L of autoclaved TB broth with 10mL of seed culture (1:100 dilution). Grow at 
37°C with shaking at 225rpm till it reaches O.D=0.6. Transfer the flask to 18°C, and allow it 
to cool for an hour. Induce it with 20uM IPTG. Grow at 18°C with shaking at 225rpm for 16 
hours.  
3. Harvest cells by centrifuging at 4000rpm for 40minutes. Discard the supernatant and store 
the pellet at -20°C, or use it immediately for further purification. 
Purification: 
1. Preparation of buffers: 
Buffer A: 50mM Tris, pH 8.0, 300mM sodium chloride  
Buffer B: 50mM Tris, pH 8.0, 300mM sodium chloride, 1M imidazole 
Dialysis buffer: 20 mM Tris, pH 8.0 
Buffer QA: 20 mM Tris, pH 7.5.  
Buffer QB: 20 mM Tris, pH 7.5, 1M NaCl 
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2. Preparation of affinity column: Take 2ml Ni-NTA agarose resin (Qiagen #30230) in affinity 
column and decant the supernatant. Continue to wash the resin 3 to 5 times with Buffer 1 (table 
5.1) to completely remove the ethanol. 
Buffer Vol. (ml) Imidazole (mM) Buffer A (ml) Buffer B (ml) 
1 50 5 49.75 0.25 
2 50 10 49.5 0.5 
3  50 25 48.75 1.25 
4  50 40 48 2 
5 50 80 46 4 
6 50 120 44 6 
7 50 160 42 8 
8 50 200 40 10 
9 50 250 37.5 12.5 
10 50 300 35 15 
11 50 500 25 25 
12 50 1000 0 50 
 
Table 5.1. Preparation of buffers for affinity purification 
 
3. Resuspend the frozen pellet in Buffer A. Add 3mg lysozyme, 1 tablet of EDTA-free protease 
inhibitor, 1mM of PMSF. Incubate the cell suspension at room temperature for 20 min. 
4. Lyze the cells using French press. Repeat the cell lysis cycle for 4 times. Remove the insoluble 
cell debris by centrifugation at 8000rpm for 1 hour at 4 °C. 
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5. Load the lysate to the affinity column and incubate with the prepared Ni-NTA agarose resin at 
4 °C for 1 hour on a nutator.  
6. Wash the resin sequentially with 20 ml of Buffer 1-12 (listed in table 5.1). 
7. Check the fractions 1-12 with SDS-PAGE (200V, ~35min).  
8. Pool the fractions containing target protein, and dialyse in 1 L of dialysis buffer at 4 °C. 
9. Further purify the protein using Resource Q column (GE Healthcare #17-1177-01) on FPLC. 
Run a Linear gradient (0-100%B) in 12 CV; 1.5 ml/fraction at a flow rate of 2 ml/min.  
10. Check the fractions with SDS-PAGE. (Figure 5.3) 
11. Pool the fractions, which contains the desired protein. 
 
 
Figure 5.3 Gel analysis of purified fractions obtained after anion exchange of Cel48F-Cutinase. 
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5.3.3 Conjugation study of Cel48F with bi-functional polymer 	
 
 
Figure 5.4 Scheme of conjugation reaction between modified Cel48F and bifunctional polymer 
linker 
 
Optimizing the conjugation conditions  
 
Figure 5.5 SDS-PAGE analysis of Cel48F-cutinase with bifunctional polymer. The samples 
were incubated at different ratios for 6, 24, 48 and 72 hours. The dimerization was observed at 
pH 6.0, at a temperature of 37°C after 6 hours.  	
1. Preparation of sample buffer: Add 50ul BME to 950ul of SDS buffer (as per the instructions: 
Laemmli Sample Buffer Bio-Rad Catalog #1610737) 
2. Incubate 500ul protein (5mM Tris maleate, pH 6, 100mM NaCl) with DODEG polymer at 
37°C at different E:L ratio: 1:0 1:1, 1:2, 2:1, 4:1, 1:10, 1:20.  
3. Aliquot 50ul of samples after 6, 24, 48 and 72 hours. 
4. Prepare 1:1 dilution of sample: sample buffer. 
5. Heat the samples at 70°C for 5 minutes. 
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6. Load 25ul to the mini-protean gels. Run the gel at 200V for 35minutes.  
Dimerization was observed at 1:1, 1:2, 2:1, 4:1 after 6 hours, indicating that the enzyme 
conjugated with both the ends of the bi-functional polymer (Figure 5.5). When a higher 
concentration of polymer was used, no dimerization was observed (as in the case of 1:10, and 
1:20) (data not shown). 
Kinetics study for conjugation 
1. Prepare 4uM of Cel48F cutinase in 20mM Tris, pH 8, 100mM NaCl. 
2. Prepare 0.1M stock solution of DOPEG in DMSO. Dilute the stock solution to 200uM using 
the same buffer as above. (At 1:50 ratio, the dimer formation is suppressed). 
3. The linker was added just before the UV analysis. 
4. Monitor the release of p-nitrophenol of the reaction at 401nm using high throughput UV 
spectrophotometer for 15 minutes.  
5. The linker was added just before the UV analysis. 
6. Monitor the release of p-nitrophenol of the reaction at 401nm using high throughput UV 
spectrophotometer for 15 minutes.  
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Figure 5.6 Determination of the rate constant for ligand functionalization of Cel48F-Cutinase 
EG10 bisphosphonate ligand by monitoring the release of p-nitrophenol at 401 nm. Data were fit 
to a pseudo-first order kinetic equation and divided by the concentration of the excess species to 
yield effective second order rate constants for the reactions.   
 
The rate constant of the reaction between enzyme and the bisphosphonate linker was obtained by 
following the release of p-nitrophenol (λmax = 401nm) with time using UV-Vis absorption 
spectroscopy (Figure 5.6). The resulting kinetic trace was fit to a pseudo-first order equation and 
the effective second-order rate constant was obtained by dividing these quantities by the 
concentration of excess ligand. The observed rate constant was found to be 37.10 M-1s-1. 
5.3.4 Cellulase activity assay of the fusion protein 	
Preparation of solutions: 
Solution 1: Potassium ferricyanide solution (0.5g/L) 
Solution 2: Carbonate-cyanide solution: (5.3g/L sodium carbonate and 0.65g/L potassium 
cyanide) 
Solution 3: Ferric ammonium solution: (1.5g/L ferric ammonium sulfate, 2g/L SDS and 0.2N 
sulfuric acid) 
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Figure 5.7 Mechanism of ferricyanide reducing sugar assay. The intensity of Prussian blue color 
is monitored at 690nm.  
 
Protocol for performing ferricyanide reducing sugar assay: The mechanism of the assay [18] 
is explained in Figure 5.7.  
1. To 300ul of sample, add 100ul of solution 1 and 100ul of solution 2. 
2. Heat at 100°C for 15minutes. 
3. Cool on ice for 3minutes. 
4. Add 500ul of solution 3 to the mix.  
5. Wait for 15 minutes. Examine the Prussian blue color formation. 
6. Measure absorbance at 690nm (scan between 645-735nm). (Replace sample solution with 
buffer to use as your blank). 
Cellulase activity assay 
1. Perform buffer exchange of Cel48F-cutinase with 20 mM Tris maleate, pH 6.0, 100mM 
NaCl, 1 mM CaCl2 using amicon fliter (Mw. Cut off 30kD).  
2. Incubate the protein with DODEG polymer at 1:1 ratio.  
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Figure 5.8 Avicel hydrolysis by Cel48F-Cutinase in free state (blue trace) or conjugated state 
(red trace). 
 
3. Incubate 1uM of protein in free and conjugated state with 4ml of microcrystalline cellulose 
(Avicel PH101, Fluka, Buchs, Switzerland) at 20mg/ml in 20 mM Tris maleate, pH 6.0, 1 
mM CaCl2.  
4. Aliquot 0.6ml at 0, 1, 5 and 24h, centrifuge and transfer the supernatant to a new 1.5ml 
eppendorf tube. Examine for soluble reducing sugars using ferricyanide assay.  
Figure 5.8 compares the amount of soluble sugars released at different time intervals by the same 
amount of proteins, either in the free state or in the conjugated state with bifunctionalized 
polymer. The hydrolytic activity of Cel48F is retained upon conjugation and is comparable to 
free form.  
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Figure 5.9 Avicel hydrolysis by Cel48F-SNAP in free state.  
Additionally, we purified Cel48F-SNAP using the same purification protocol. The cellulase 
activity of the fusion protein was observed in the free form as depicted in Figure 5.9. While the 
polymers for Cel48F-SNAP are currently being synthesized, we tested its ability to conjugate 
with commercially available benzylguanine functionalized magnetic beads. We were successful 
in our attempt to immobilize the Cel48F-SNAP on magnetic capture beads.  
5.4 Conclusions and Future directions 	
We were able to successfully create differently tagged cellulases that retain the cellulase activity 
and can further be conjugated with functionalized polymers. The conjugated enzyme (Cel48F-
Cutinase) has a similar activity as its free form, however we strive to achieve a better activity 
profile. This can be observed by attaching cellulases from different families that work 
synergistically with Cel48F enzyme. Additionally, HPLC assay would provide quantitative 
results in measuring the hydrolytic activity of cellulases. It will also be interesting to develop 
brush polymer having multiple chain ends, which can be used to conjugate cellulase. Finally, this 
work serves as a foundation to prepare supramolecular assembly of enzymes conjugated to 
polymeric scaffolds using different bio-orthogonal chemistry.  
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Chapter 6. Conclusions 
6.1 Summary and future outlook 
 
Much can be learned about proteins using biophysical and biochemical approaches. Each protein 
was investigated from a different perspective. Below, we highlight the conclusions of our studies 
on different protein systems, namely integrin-Src, CaM and Cellulase, and offer additional 
insights in further exploring these systems.  
Extensive studies of both, integrin and Src kinase, have established a critical role of this 
interaction in thrombosis and hemostasis as well as in regulation of platelet adhesion. Src kinase 
plays an important role in integrin signaling by regulating cytoskeletal organization and cell 
remodeling. Previous in vivo studies revealed that SH3 domain of c-Src kinase directly 
associates with the C-terminus of β3 integrin cytoplasmic tail. Here, we explored this binding 
interface with a combination of different spectroscopic and computational methods. Chemical 
shift mapping, PRE, transferred NOE and CD data were used to obtain a docked model of the 
complex. This model suggests a different binding mode from the one proposed through previous 
studies wherein, the C-terminal end of β3 spans the region in between the RT and n-Src loops of 
SH3 domain. Furthermore, we show that tyrosine phosphorylation of β3 prevents this interaction, 
supporting the notion of a constitutive interaction between β3 integrin and Src SH3. We, further 
investigated the effect of tyrosine phosphorylation of β3, and identified its interaction with Src 
SH2. The platelet stimulation studies performed by another group corroborate our results, 
supporting the notion that Src can remain bound to activated β3. With identification of this novel 
binding mode, a variety of questions still remain unanswered. How integrin mediates Src 
activation, what is the role of β3BP in binding to Src SH2, does it displace the pY527 bearing C-
terminal tail or are there any conformational changes associated with it? Proposed ITC studies 
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can identify the binding affinity and thermodynamic forces driving the interaction between SH2 
domain and β3 CT in different phosphorylation states. Based on the Kd values, we can further 
provide insights into the mechanism of integrin mediated Src activation. It would also be 
interesting to prepare Src SH2 deletion mutants and further study the functional relevance of 
these interactions using cell-based assays.  
In our second project, we focused our research efforts in understanding the effect of protein 
modification on protein’s internal structure and its interaction with its binding partner. 
Calmodulin, a calcium modulated protein was modified using a disulfide linkage. A subtle 
change in the structure was enough to alter the enthalpy-entropy contributions, however, it was 
remarkable to observe that the free energy remain constant. To further qualify these changes, we 
studied the backbone dynamics of CaM. Despite the conformational change of the protein, the 
flexibility of backbone residues weren’t significantly affected. Previous studies identified that 
dynamics of side chains (of wt-CaM) contribute significantly to the binding of smMLCK. It 
would be useful to study the dynamics of side chain residues and identify the factors contributing 
to the enthalpy-entropy compensation. Besides, one can also perform H-D exchange experiments 
in apo and bound forms to study the effect of solvation that contributes significantly to the 
entropy term.  
Lastly, we investigated engineered proteins and developed its conjugates. Our engineered 
proteins and their conjugates maintain their cellulase activity in solution. We strive to achieve 
better activity of these enzyme-polymeric conjugates. Additionally, we aim to develop artificial 
cellulosome, consisting of a polymeric scaffold, which remains stable at extreme conditions used 
in industries. These artificial systems would be prepared by using brush polymers decorated with 
different functional groups to which differently tagged proteins can attach.  
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Taken together, our studies used multifarious approaches to improve and contribute to the 
existing knowledge of proteins involved in cell signaling pathways; addressing the physical 
impact of topological constrain on proteins; and developing a general route to site specifically 
link proteins to polymeric scaffolds.  	
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